Source:http://linkedlifedata.com/resource/pubmed/id/11365494
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1998-9-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
X
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1551-8396
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11365494-Adolescent,
pubmed-meshheading:11365494-Adult,
pubmed-meshheading:11365494-Anti-HIV Agents,
pubmed-meshheading:11365494-Delavirdine,
pubmed-meshheading:11365494-HIV Infections,
pubmed-meshheading:11365494-Humans,
pubmed-meshheading:11365494-Nevirapine,
pubmed-meshheading:11365494-Reverse Transcriptase Inhibitors
|
pubmed:year |
1998
|
pubmed:articleTitle |
Late breaking news: two additional DHHS guidelines changes. Department of Health and Human Services.
|
pubmed:publicationType |
Newspaper Article
|